Skip to content

Clinical trials

Withdrawn Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Status: Withdrawn Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20111
20123
20132
20143
20193
20201
20212
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Adapt Produtos Oftalmológicos Ltda.1
Allergan1
Aston University1
Bausch & Lomb Incorporated1
BelkinVision1
Care Team Solutions1
Columbia University1
EyeCool Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension24
Glaucoma, Open-Angle14
Glaucoma9
Eye Diseases3
Anxiety Disorders1
Blindness1
Cataract1
Diabetic Retinopathy1
Graves Disease1
Graves Ophthalmopathy1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.